Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06556628 · ClinicalTrials.gov registry record

Tympanic Thermometer Study

A clinical trial of Fever and Body Temperature Changes, sponsored by Baxter Healthcare Corporation.

Active
Registry status
1,000
Enrollment target
1
Study location

NCT06556628 is a study of Fever and Body Temperature Changes that is active but no longer recruiting, run by Baxter Healthcare Corporation. The registered enrollment target is 1,000 participants, above the 544-participant average among 18 other Fever trials with a reported enrollment target (84% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06556628, a study of Fever and Body Temperature Changes, is active but no longer recruiting, sponsored by Baxter Healthcare Corporation.

ACTIVE NOT RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to collect febrile, healthy, and in some instances cold temperature data from human subjects ranging from newborns to geriatrics. This data will be used to develop a new thermometer.

Interventions

  • DEVICE Increased Body Temperatures

Study Locations (1)

New York

  • Baxter - Skaneateles

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2022-04-11
Est. Completion 2025-05-31

Sponsor

Baxter Healthcare Corporation

46 total trials

What the Registry Record Tells You About NCT06556628

The ClinicalTrials.gov registry entry for NCT06556628 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 544-participant average among 18 other Fever trials with a reported enrollment target (84% higher). The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Fever appearing as the primary indexed condition, and to 1 intervention - of which Increased Body Temperatures is the first listed.

NCT06556628 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06556628 about?

NCT06556628 is a clinical study titled "Tympanic Thermometer Study". The goal of this study is to collect febrile, healthy, and in some instances cold temperature data from human subjects ranging from newborns to geriatrics. This data will be used to develop a new thermometer.

What is the current status of trial NCT06556628?

This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2022-04-11. Estimated completion is 2025-05-31.

What conditions does trial NCT06556628 study?

This clinical trial studies the following conditions: Fever, Body Temperature Changes.

What interventions are being tested in trial NCT06556628?

The interventions under investigation include: Increased Body Temperatures (DEVICE).

Who is sponsoring clinical trial NCT06556628?

This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06556628 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fever

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.